Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Predictive models assessing the response to ustekinumab highlight the value of therapeutic drug monitoring in Crohn's disease.
Dig Liver Dis. 2023 Mar;55(3):366-372. doi: 10.1016/j.dld.2022.07.015. Epub 2022 Aug 14.
Dig Liver Dis. 2023.
PMID: 35977875
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases.
Liefferinckx C, Bottieau J, Toubeau JF, Thomas D, Rahier JF, Louis E, Baert F, Dewint P, Pouillon L, Lambrecht G, Vallée F, Vermeire S, Bossuyt P, Franchimont D.
Liefferinckx C, et al. Among authors: bottieau j.
Inflamm Bowel Dis. 2022 Feb 1;28(2):208-217. doi: 10.1093/ibd/izab042.
Inflamm Bowel Dis. 2022.
PMID: 33783494
Item in Clipboard
Cite
Cite